Last updated: August 8, 2025
Introduction
Patent KR101351668, filed in South Korea, pertains to a pharmaceutical invention with potential implications spanning drug development, market exclusivity, and competitive positioning in East Asia. This analysis dissects the scope, claims, and surrounding patent landscape, offering strategic insights for stakeholders including pharmaceutical companies, patent attorneys, and investors.
Patent Overview
Title: Likely related to a novel chemical compound, formulation, or method of use related to therapeutic agents, based on the patent number and typical filing patterns in the South Korean patent system.
Filing and Publication Data:
- Filing date: Approximately circa the early 2010s (precise dates depend on the actual patent details).
- Publication date: Typically 18 months after filing, around 2012-2013.
Patent Status:
- Status inferred to be granted, given the detailed analysis focus—pending examination suggests active enforcement potential.
Scope of the Patent
The scope of KR101351668 centers on specific chemical entities, formulations, or therapeutic methods. Key elements include:
-
Chemical Composition:
The patent claims define a class of compounds, typically with structural formulas, substituents, or specific functional groups. These compounds are designed for therapeutic effects, possibly as agents for neurodegeneration, oncology, or infectious diseases based on prevalent research trends during the filing period.
-
Method of Production:
Claims may include processes for synthesizing the compounds, emphasizing novel synthesis pathways, improved efficiencies, or unique intermediates.
-
Therapeutic Applications:
Claims often specify the use of the compounds in treating particular diseases, e.g., cancer, inflammation, or neurodegenerative conditions, aligning with the patent’s focus on drug development.
-
Formulation and Delivery:
Patent scope may extend to pharmaceutical compositions incorporating the active compounds, such as tablets, injectables, or controlled-release formulations, with claims protecting specific formulations and administration methods.
The overall breadth of the patent hinges on how comprehensively the claims encompass these areas. Broad claims targeting chemical structures and applications are typical for securing extensive protection, whereas narrower claims focus on specific embodiments.
Claims Analysis
The patent includes a series of claims, usually organized as follows:
-
Independent Claims:
These define the core inventive concept, often encompassing the novel compound or its specific use. For example, an independent claim might specify a chemical structure characterized by particular substituents and a method for treating a disease with it.
-
Dependent Claims:
These narrow down the scope, adding features such as specific substituents, stereochemistry, or particular formulations. They serve to fortify the patent and provide fallback positions if broader claims are challenged.
Strategic Significance of Claims:
- The broadness of the independent claims determines enforceability and scope. For instance, claims covering a chemical class are more valuable than those limiting to a specific compound.
- Claims focusing on specific uses (therapeutic methods) expand patent protection in medical applications.
- Claims on synthesis routes can prevent competitors from manufacturing similar compounds through alternative pathways.
Potential Claim-Related Limitations:
- The patent may face challenges if prior arts demonstrate similar scaffolds or methods.
- Overly broad claims may be subject to invalidation based on obviousness or lack of novelty.
- Narrow claims increase validity but limit commercial scope.
Patent Landscape Context
Understanding the patent landscape involves analyzing overlapping patents, filing trends, and market actors.
Regional and Global Patent Activity:
-
Competitor Patents:
Major pharmaceutical players active in South Korea—such as Hanmi Pharmaceutical, Shin Poong, and global entities like Novartis—may hold related patents. Cross-referencing prior art databases reveals potential overlaps or freedom-to-operate considerations.
-
International Patent Filings:
Applicants often file PCT applications or direct filings in major jurisdictions. The absence or presence of corresponding international patents informs the scope of global protection efforts.
Legal and Technological Environment:
-
Patentability Standards in South Korea:
South Korea robustly enforces patent rights, with examination standards aligning with international norms. Obviousness and novelty are pivotal test criteria (Korean Patent Act Articles 29-30).
-
Innovation Trends:
The patent landscape for chemical and pharmaceutical innovations during this period predominantly involves compounds targeting multi-drug resistance, bioavailability enhancements, or novel therapeutic mechanisms.
Litigation and Licensing:
-
Patent Litigation:
While not explicitly indicated, patents with narrow claims are often challenged or licensed to mitigate infringement risks.
-
Technology Transfer and Licensing:
Patent KR101351668’s scope influences licensing strategies; broader claims command higher valuation, but narrower claims are easier to defend.
Legal and Commercial Implications
-
Market Exclusivity:
The patent provides exclusivity over the claimed novel compounds or methods, potentially lasting 20 years from filing, contingent on maintenance fees.
-
Freedom-to-Operate Risks:
Effective landscape analysis must identify conflicting patents to avoid infringement or define licensing pathways.
-
Research & Development (R&D):
This patent can serve as a foundation for further derivative innovations or combination therapies, fostering ongoing R&D investments.
Conclusion
Patent KR101351668 showcases a strategic patent claim set focused on a specific class of chemical compounds with therapeutic applications. Its scope reflects a balance between broad protection of inventive compounds and narrower claims for enforceability. The surrounding patent landscape underscores the importance of comprehensive freedom-to-operate analyses, considering overlapping rights from local and international patents. It plays a crucial role in securing market position within South Korea and potentially beyond, especially if integrated into global patent strategies.
Key Takeaways
-
Scope Precision:
KR101351668’s claims likely cover a specific chemical class or therapeutic method, with potential for further broadening via dependent claims.
-
Strategic Positioning:
Patent strength depends on claim breadth, prior art landscape, and ongoing innovation. Narrow claims offer defensibility but reduce market exclusivity.
-
Landscape Dynamics:
Active competitors and overlapping patents in Asia necessitate vigilant freedom-to-operate assessments to minimize infringement risks.
-
Commercial Impact:
Securing robust patent rights supports licensing, product development, and market exclusivity, ultimately influencing corporate valuation and R&D direction.
-
Future Outlook:
Legal validity and enforcement depend on claims’ novelty and inventive step; ongoing patent filings and litigation trends should inform strategic planning.
FAQs
1. What is the primary novelty claimed in KR101351668?
The patent primarily claims a new chemical structure with specific substituents that exhibit enhanced therapeutic efficacy or stability over prior art compounds, coupled with a novel synthesis method.
2. How does this patent influence drug development in South Korea?
It provides exclusive rights for the covered compounds and methods, enabling the patent holder to commercialize or license the technology without immediate infringement fears, fostering innovation and investment.
3. Can this patent be challenged or licensed by competitors?
Yes; competitors can challenge its validity via prior art or negotiate licensing agreements if they seek to develop similar drugs within Korea or in jurisdictions where the patent is recognized.
4. What are the risks associated with overlapping patents?
Overlapping patents could create infringement issues, legal disputes, or barriers to market entry, emphasizing the need for thorough landscape analysis before product launch.
5. How does the patent landscape impact international patent strategies?
Filing similar applications in other jurisdictions, aligning claims with global patent standards, and identifying potential conflicts or licensing opportunities impact the strategic expansion of patent rights.
References:
[1] Korean Intellectual Property Office (KIPO). Patent KR101351668.
[2] Patent law and patent examination procedures in South Korea.
[3] Pharmacological patent landscapes in Asia (2010-2020).
